Interventions for preventing oral mucositis for patients with cancer receiving radiotherapy
Interventions for preventing oral mucositis for patients with cancer receiving radiotherapy
Cochrane Review
9 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Mortality
therapeutic (delayed) ND |
0.64 | - | - | Not assessed |
|
New disease, progression, and mortality
therapeutic (delayed) ND |
0.56 | - | - | Not assessed |
|
Locoregional recurrence
therapeutic (delayed) ND |
0.58 | - | - | Not assessed |
|
Recurrence
therapeutic (delayed) ND |
0.58 | - | - | Not assessed |
|
Adverse events associated with treatment
therapeutic (delayed) ND |
1.31 | - | - | Not assessed |
|
Total mortality
elective selective ND |
nan | - | - | Not assessed |
|
New disease, progression or mortality
therapeutic (delayed) neck dissection |
0.73 | - | - | Not assessed |
|
Adverse events
therapeutic (delayed) neck dissection |
nan | - | - | Not assessed |
|
Disease free survival
planned neck dissection either before or after chemoradiotherapy |
nan | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD006205 |
| Outcomes: | 9 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
9